In this webcast, Catalent will share a case study of a monoclonal antibody (mAb) from clinical to commercial phase under a highly compressed timeline. Process characterization and validation is an ...

Monoclonal antibodies (mAbs) have revolutionized modern medicine, offering precision therapies for cancer, autoimmune disorders, infectious diseases, and numerous other advantages. The global mAb ...

Process intensification (PI) enhances the efficiency, flexibility, and sustainability of complex molecule manufacturing by reducing costs and increasing throughput. That is why the monoclonal antibody ...

Resolving operational bottlenecks makes mAb manufacturing more efficient. Traditional biologics, which are predominantly monoclonal antibodies (mAbs), are continuing to see strong market demand, and ...